NCT05898399
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05898399
Title Study of ART6043 in Advanced/Metastatic Solid Tumors Patients
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Artios Pharma Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
South Texas Accelerated Research Therapeutics (START) - Midwest Grand Rapids Michigan 49546 United States Details
Memorial Sloan-Kettering Cancer Center (MSKCC) New York New York 10065-6800 United States Details
Stephenson Cancer Center - Oncology Oklahoma City Oklahoma 73104 United States Details
Jefferson University Hospitals - Kimmel Cancer Center Philadelphia Pennsylvania 17107 United States Details
SCRI oncology partners Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Center - Clinic Dallas Texas 75251 United States Details
The University of Texas - MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field